The National Lung Cancer Audit: The Impact of COVID-19

被引：10

作者：

Conibear, J. ^{[1
,7
]}

Nossiter, J. ^{[2
,3
]}

Foster, C. ^{[2
,3
]}

West, D. ^{[4
]}

Cromwell, D. ^{[2
,3
]}

Navani, N. ^{[5
,6
]}

机构：

[1] St Bartholomews Hosp, Barts Canc Ctr, London, England

[2] London Sch Hyg & Trop Med, Dept Hlth Serv Res & Policy, London, England

[3] Royal Coll Surgeons England, Clin Effectiveness Unit, London, England

[4] Univ Hosp Bristol NHS Fdn Trust, Div Surg, Bristol, England

[5] UCL, Lungs Living Res Ctr, UCL Resp, London, England

[6] Univ Coll London Hosp, Dept Thorac Med, London, England

[7] St Bartholomews Hosp, Barts Canc Ctr, London EC1A 7BE, England

来源：

CLINICAL ONCOLOGY | 2022年 / 34卷 / 11期

基金：

英国医学研究理事会;

关键词：

cancer; COVID-19; improvement; lung; national; NHS; NLCA; pandemic; surgery; survival;

D O I：

10.1016/j.clon.2022.09.002

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Since 2014, the National Lung Cancer Audit (NLCA) has been evaluating the performance of the UK NHS lung cancer services against established standards of care. Prior to the onset of the COVID-19 pandemic, the NLCA's annual reports revealed a steady stream of improvements in early diagnosis, access to surgery, treatment with anti-cancer therapies, input from specialist nursing and survival for patients with lung cancer in the NHS. In January 2022, the NLCA reported on the negative impact COVID-19 has had on all aspects of the lung cancer diagnosis and treatment pathway within the NHS. This article details the fundamental changes made to the NLCA data collection and analysis process during the COVID-19 pandemic and details the negative impact COVID-19 had on NHS lung cancer patient outcomes during 2020.Crown Copyright (c) 2022 Published by Elsevier Ltd on behalf of The Royal College of Radiologists. All rights reserved.

引用

页码：701 / 707

页数：7

共 22 条

[1]

[Anonymous], 2022, NATL LUNG CANC AUDIT

[2] Changes in the Management of Patients having Radical Radiotherapy for Lung Cancer during the First Wave of the COVID-19 Pandemic in the UK [J].

Banfill, K. ;

Croxford, W. ;

Fornacon-Wood, I ;

Wicks, K. ;

Ahmad, S. ;

Britten, A. ;

Carson, C. ;

Dorey, N. ;

Hatton, M. ;

Hiley, C. ;

Jayaprakash, K. Thippu ;

Jegannathen, A. ;

Koh, P. ;

Panakis, N. ;

Peedell, C. ;

Pope, A. ;

Powell, C. ;

Stilwell, C. ;

Thomas, B. ;

Toy, E. ;

Wood, V ;

Yahya, S. ;

Zhou, S. Y. ;

Price, G. ;

Faivre-Finn, C. .

CLINICAL ONCOLOGY, 2022, 34 (01) :19-27

[3]

Cancer Research UK, 2022, Lung cancer statistics

[4]

European Cancer Information System, 2022, EST INC MORT

[5] Reduced Fractionation in Lung Cancer Patients Treated with Curative-intent Radiotherapy during the COVID-19 Pandemic [J].

Faivre-Finn, C. ;

Fenwick, J. D. ;

Franks, K. N. ;

Harrow, S. ;

Hatton, M. Q. F. ;

Hiley, C. ;

McAleese, J. J. ;

McDonald, F. ;

O'Hare, J. ;

Peedell, C. ;

Pope, T. ;

Powell, C. ;

Rulach, R. ;

Toy, E. .

CLINICAL ONCOLOGY, 2020, 32 (08) :481-489

[6]

Healthcare Quality Improvement Partnership, 2022, NAT QUAL IMPR PROGR

[7]

Lung Clinical Expert Group, NAT OPT LUNG CANC PA

[8] The impact of the COVID-19 pandemic on cancer deaths due to delays in diagnosis in England, UK: a national, population-based, modelling study [J].

Maringe, Camille ;

Spicer, James ;

Morris, Melanie ;

Purushotham, Arnie ;

Nolte, Ellen ;

Sullivan, Richard ;

Rachet, Bernard ;

Aggarwal, Ajay .

LANCET ONCOLOGY, 2020, 21 (08) :1023-1034

[9]

National Health Service (NHS), 2019, NHS LONG TERM PLAN

[10]

National Institute for Health and Care Excellence (NICE), 2019, method and its engineering application to lung cancer diagnosis

← 1 2 3 →